tirzepatide pancreatitis warning People using GLP-1 weight-loss injections such as Wegovy have been advised to stay alert to a rare but serious risk of acute pancreatitis, a severe inflammation of the pancreas. The Medicines and Small risk of severe acute

Disclaimer The contents of this page are meant for licensed medical professionals

If youre considering stopping tirzepatide, we may recommend a gradual reduction in the medication, paired with increased support for nutrition, physical activity, and behavioral strategies to help you maintain your results

What researchers can do to protect themselves Several practical strategies can help researchers navigate this imperfect market

The subcutaneous tissue in these areas provides appropriate depth for medication depot formation, allowing for the sustained release profile necessary for once-weekly dosing

Strict Routine: Must be taken on an empty stomach with no more than 4 ounces of water

A gradual dose escalation is the primary strategy used to improve tolerability and ensure you can continue with the therapy